Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Gynecological Examination Chairs Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Growing prevalence of gynecological disorders
3.4.1.2. Technological advancements
3.4.1.3. Rising investments in the healthcare sector globally
3.4.2. Market restraint analysis
3.4.2.1. High cost associated with gynecological examination chairs
3.4.2.2. Under-developed healthcare infrastructure in developing nations
3.5. Gynecological Examination Chairs Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Gynecological Examination Chairs Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Electric
4.1.2. Non-electric
4.2. Type Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Gynecological Examination Chairs Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Electric
4.5.1.1. Electric market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Non-electric
4.5.2.1. Non-electric market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Gynecological Examination Chairs Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Gynecological cancer
5.1.2. Menstrual disorders
5.1.3. Hysterectomy
5.1.4. Pregnancy complications
5.1.5. Others
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Gynecological Examination Chairs Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Gynecological cancer
5.5.1.1. Gynecological cancer market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Menstrual disorders
5.5.2.1. Menstrual disorders market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Hysterectomy
5.5.3.1. Hysterectomy market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Pregnancy complications
5.5.4.1. Pregnancy complications market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Others
5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Gynecological Examination Chairs Market: End Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals & Clinics
6.1.2. Outpatient Facilities
6.1.3. Others
6.2. Sales Channel Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Gynecological Examination Chairs Market by End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals & Clinics
6.5.1.1. Hospitals & clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Outpatient Facilities
6.5.2.1. Outpatient facilities market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Gynecological Examination Chairs Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2022
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 – 2030
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 – 2030
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 – 2030
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 – 2030
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 – 2030
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 – 2030
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 – 2030
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 – 2030
7.8.6. Sweden
7.8.6.1. Market estimates and forecast, 2018 – 2030
7.8.7. Denmark
7.8.7.1. Market estimates and forecast, 2018 – 2030
7.8.8. Norway
7.8.8.1. Market estimates and forecast, 2018 – 2030
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2018 – 2030
7.9.2. China
7.9.2.1. Market estimates and forecast, 2018 – 2030
7.9.3. India
7.9.3.1. Market estimates and forecast, 2018 – 2030
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2018 – 2030
7.9.5. Thailand
7.9.5.1. Market estimates and forecast, 2018 – 2030
7.9.6. Australia
7.9.6.1. Market estimates and forecast, 2018 – 2030
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 – 2030
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 – 2030
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 – 2030
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2018 – 2030
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2018 – 2030
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 – 2030
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 – 2030
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. medifa
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Zhangjiagang Medi Medical Equipment Co., ltd.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Novak M.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. SCHMITZ
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Ocura
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Tromwind industries Co. Limited
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. AGA SANITÄTSARTIKEL GMBH
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Malvestio Spa
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Favero Health Projects Spa
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/